Overview

Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare buprenorphine transdermal delivery system (BTDS) with standard- treatment in subjects with osteoarthritis (OA).
Phase:
Phase 4
Details
Lead Sponsor:
Napp Pharmaceuticals Limited
Treatments:
Acetaminophen
Buprenorphine
Codeine